Analyst Price Targets — JUSHF
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 13, 2024 6:37 am | Bobby Burleson | Canaccord Genuity | $1.50 | $0.69 | TheFly | Jushi Holdings price target raised to $1.50 from $1.25 at Canaccord |
| November 23, 2022 8:15 am | — | Cantor Fitzgerald | $2.35 | $1.72 | Benzinga | Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Raises Price Target to $2.35 |
| September 1, 2022 5:23 am | — | Cantor Fitzgerald | $2.25 | $1.92 | Benzinga | Cantor Fitzgerald Maintains Neutral on Jushi Holdings, Lowers Price Target to $2.25 |
| May 26, 2022 10:52 am | Pablo Zuanic | Cantor Fitzgerald | $2.50 | $1.90 | Benzinga | Cannabis Reform Is 'By Far The Main Catalyst,' Analyst Discusses Jushi's Q4 Financial Results |
Latest News for JUSHF
A Media Snippet accompanying this announcement is available by clicking on this link.
InMode (NASDAQ: INMD - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Valuation and Earnings This table compares InMode and Jushi"s
This week could be a big trading week for marijuana stocks to kick off 2026. At this time, there is a lot of speculation on what is next to come. These thoughts have been had for a long time, while most legal operators have been working in a grey area. Now that cannabis is considered a less harmful substance in the eyes of the government, more progress can be made. Not just that, for most marijuana stock investors,…
Resonate Blends (OTCMKTS:KOAN - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends. Risk and Volatility Resonate Blends has a beta
InterCure (NASDAQ: INCR - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. Insider and Institutional Ownership 8.3% of InterCure shares are held
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for JUSHF.
U.S. House Trading
No House trades found for JUSHF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.